<DOC>
	<DOCNO>NCT02665806</DOCNO>
	<brief_summary>This study design compare ciclesonide nasal spray daily fluticasone propionate aqua nasal spray BD , commonly prescribed patient nasal polyposis , order relieve symptom patient .</brief_summary>
	<brief_title>Ciclesonide v Fluticasone Nasal Sprays Nasal Poplyposis</brief_title>
	<detailed_description>The study conduct tertiary ENT center Tehran . Endoscopic severity grade patient determine polyps basis 3 point classification system : 1 , confine middle meatus ; 2 , level middle turbinate ; 3 , cause total obstruction . Also , patient undergo paranasal sinus CT scan determine Lund-Mackay stage define sum score 12 paranasal sinus ( 0 completely lucent , 1 partially opaque 2 completely opaque sinus ) . Patients randomize treat one two group : 1 month therapy fluticasone propionate aqueous nasal spray ( FPANS ) 200 µg twice day 1 month therapy intranasal ciclesonide spray 200 µg daily . All patient give write , easy understand instruction use nasal spray . All include patient ask answer disease specific Persian language validate SNOT20 quality life questionnaire evaluate symptom severity start treatment . SNOT20 symptom severity health relate quality life measure sinonasal diseases contain 20 question CRS relate symptom . Symptoms severity score 0 , indicate problem 5 , indicate bad possible symptom . Then score 20 item add produce total score range 0 100 . After one month treatment patient visit blind physician ass symptom . Then patient answer SNOT20 questionnaire . Patients give chance report problem drug administration enquire adverse effect end 1 month treatment physician . Withdrawals define drug study discontinuation due adverse effect lack efficacy . By consider 5 % level significance , 90 % power detect clinically important difference 0.6 point two group improve total score SNOT20 assume standard deviation ( SD ) 0.6 , include 22 case study arm . To address 10 % probable loss follow , would recruit 24 case arm . The continuous variable show mean ± SD . The categorical variable present frequency percentage . The normality measure outcome variable test graphically well statistically Shapiro-Wilk test . In case normal distribution would use parametric t-test compare mean value two group . Otherwise would use non-parametric Mann-Whitney test . Chi-squared Fischer-exact test use compare categorical variable . All statistical analysis conduct use IBM SPSS statistic Windows , version 23.0 , ( Armonk , NY : IBM Corp. ) .</detailed_description>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Individuals diagnosis symptomatic nasal polyposis include . Objective confirmation chronic rhinosinusitis polyp do paranasal sinuses CT scan Endoscopy . Administration systemic corticosteroid last 3 month Administration antihistamine , nasal steroid 15 day prior include study . History surgical treatment last 3 month . History septal deviation , severe epistaxis , cystic fibrosis , severe noncontrolled asthma , current purulent nasal infection , allergic rhinitis . Hypersensitivity contraindication steroid . Any positive history suspect influence study parameter . NP require systemic corticosteroid daily use saline irrigation .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Ciclesonide</keyword>
	<keyword>Fluticasone propionate</keyword>
	<keyword>Nasal Polyposis</keyword>
	<keyword>Chronic Sinuitis</keyword>
	<keyword>Chronic rhinosinusitis</keyword>
</DOC>